Thrombocytopenia differential diagnosis: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
No edit summary
No edit summary
Line 13: Line 13:
! colspan="3" |Laboratory findings
! colspan="3" |Laboratory findings
! rowspan="2" |Pathology
! rowspan="2" |Pathology
! rowspan="2" |Other specifics
|-
|-
|[[White blood cells|WBC]] changes
|[[White blood cells|WBC]] changes
Line 26: Line 27:
* ↑ [[Erythrocyte sedimentation rate|ESR]]
* ↑ [[Erythrocyte sedimentation rate|ESR]]
* ↑ [[Rheumatoid factor|RF]], [[Blood urea nitrogen|BUN]] and [[Creatinine|Cr]] may also be present
* ↑ [[Rheumatoid factor|RF]], [[Blood urea nitrogen|BUN]] and [[Creatinine|Cr]] may also be present
|
|
|
|-
|-
|[[pulmonary embolism]]
|[[pulmonary embolism]]<ref name="pmid241826422">{{cite journal| author=Cohen AT, Dobromirski M, Gurwith MM| title=Managing pulmonary embolism from presentation to extended treatment. | journal=Thromb Res | year= 2014 | volume= 133 | issue= 2 | pages= 139-48 | pmid=24182642 | doi=10.1016/j.thromres.2013.09.040 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24182642  }}</ref>
|
* [[Dyspnea]]
* [[Pleuritic chest pain]]
* [[Fainting]]
* [[Cough]]
* [[Substernal chest pain]]
* [[Hemoptysis]]
* [[Wheezing]]
* [[Cyanosis]]
* [[Fever]]  
|
|
|
|
Line 37: Line 49:
| rowspan="2" |'''Chemical/poisoning'''
| rowspan="2" |'''Chemical/poisoning'''
|[[Strontium-89]]
|[[Strontium-89]]
|
|
|
|
|
Line 44: Line 57:
|-
|-
|[[zinc]]
|[[zinc]]
|
|
|
|
|
Line 52: Line 66:
| rowspan="4" |'''Dermatologic'''
| rowspan="4" |'''Dermatologic'''
|[[Cholesterol embolism]]
|[[Cholesterol embolism]]
|
|
|
|
|
Line 59: Line 74:
|-
|-
|[[Elejalde syndrome]]
|[[Elejalde syndrome]]
|
|
|
|
|
Line 66: Line 82:
|-
|-
|[[Griscelli syndrome|Griscelli syndrome type 1]]
|[[Griscelli syndrome|Griscelli syndrome type 1]]
|
|
|
|
|
Line 73: Line 90:
|-
|-
|[[neuroectodermal melanolysosomal disease]]
|[[neuroectodermal melanolysosomal disease]]
|
|
|
|
|
Line 81: Line 99:
| rowspan="4" |'''Ear Nose Throat'''
| rowspan="4" |'''Ear Nose Throat'''
|[[Alport syndrome]]
|[[Alport syndrome]]
|
|
|
|
|
Line 88: Line 107:
|-
|-
|Arias oculootoradial syndrome
|Arias oculootoradial syndrome
|
|
|
|
|
Line 95: Line 115:
|-
|-
|[[Epstein's syndrome]]
|[[Epstein's syndrome]]
|
|
|
|
|
Line 102: Line 123:
|-
|-
|[[Fechtner syndrome]]
|[[Fechtner syndrome]]
|
|
|
|
|
Line 110: Line 132:
|'''Endocrine'''
|'''Endocrine'''
|[[Immunodysregulation polyendocrinopathy and enteropathy, X-linked]]
|[[Immunodysregulation polyendocrinopathy and enteropathy, X-linked]]
|
|
|
|
|
Line 118: Line 141:
| rowspan="4" |'''Gastroenterologic'''
| rowspan="4" |'''Gastroenterologic'''
|[[Aminoaciduria|Dibasic aminoaciduria type 2]]
|[[Aminoaciduria|Dibasic aminoaciduria type 2]]
|
|
|
|
|
Line 125: Line 149:
|-
|-
|[[liver failure]]
|[[liver failure]]
|
|
|
|
|
Line 132: Line 157:
|-
|-
|[[Niemann-Pick disease|Niemann-Pick disease type b]]
|[[Niemann-Pick disease|Niemann-Pick disease type b]]
|
|
|
|
|
Line 139: Line 165:
|-
|-
|[[portal hypertension]]
|[[portal hypertension]]
|
|
|
|
|
Line 147: Line 174:
| rowspan="14" |'''Genetic'''
| rowspan="14" |'''Genetic'''
|[[Aicardi-Goutieres syndrome]]
|[[Aicardi-Goutieres syndrome]]
|
|
|
|
|
Line 154: Line 182:
|-
|-
|[[Chediak-Higashi disease]]
|[[Chediak-Higashi disease]]
|
|
|
|
|
Line 161: Line 190:
|-
|-
|[[Factor H|complement factor H deficiency]]
|[[Factor H|complement factor H deficiency]]
|
|
|
|
|
Line 168: Line 198:
|-
|-
|[[Elejalde syndrome]]
|[[Elejalde syndrome]]
|
|
|
|
|
Line 175: Line 206:
|-
|-
|[[Fanconi anaemia]]
|[[Fanconi anaemia]]
|
|
|
|
|
Line 182: Line 214:
|-
|-
|[[Fechtner syndrome]]
|[[Fechtner syndrome]]
|
|
|
|
|
Line 189: Line 222:
|-
|-
|[[Griscelli syndrome|Griscelli syndrome type 1]]
|[[Griscelli syndrome|Griscelli syndrome type 1]]
|
|
|
|
|
Line 196: Line 230:
|-
|-
|[[holocarboxylase synthase deficiency]]
|[[holocarboxylase synthase deficiency]]
|
|
|
|
|
Line 203: Line 238:
|-
|-
|[[iminodipeptiduria]]
|[[iminodipeptiduria]]
|
|
|
|
|
Line 210: Line 246:
|-
|-
|[[Jacobsen syndrome]]
|[[Jacobsen syndrome]]
|
|
|
|
|
Line 217: Line 254:
|-
|-
|[[MELAS]]
|[[MELAS]]
|
|
|
|
|
Line 224: Line 262:
|-
|-
|[[Omenn syndrome]]
|[[Omenn syndrome]]
|
|
|
|
|
Line 231: Line 270:
|-
|-
|[[TAR syndrome]]
|[[TAR syndrome]]
|
|
|
|
|
Line 238: Line 278:
|-
|-
|[[X-linked hyperimmunoglobulin M syndrome]]
|[[X-linked hyperimmunoglobulin M syndrome]]
|
|
|
|
|
Line 246: Line 287:
| rowspan="33" |'''Hematologic'''
| rowspan="33" |'''Hematologic'''
|[[Acquired pure megakaryocytic aplasia]]
|[[Acquired pure megakaryocytic aplasia]]
|
|
|
|
|
Line 256: Line 298:
|<nowiki>+ / ↓</nowiki>
|<nowiki>+ / ↓</nowiki>
|<nowiki>+ / ↓</nowiki>
|<nowiki>+ / ↓</nowiki>
|
|
|
|
|
|-
|-
|[[Bernard-Soulier syndrome]]
|[[Bernard-Soulier syndrome]]
|
|
|
|
|
Line 267: Line 311:
|-
|-
|[[Thrombocytopenia|congenital amegakaryocytic thrombocytopenia (CAMT)]]
|[[Thrombocytopenia|congenital amegakaryocytic thrombocytopenia (CAMT)]]
|
|
|
|
|
Line 274: Line 319:
|-
|-
|[[disseminated intravascular coagulation]]
|[[disseminated intravascular coagulation]]
|
|
|
|
|
Line 281: Line 327:
|-
|-
|[[Epstein's syndrome]]
|[[Epstein's syndrome]]
|
|
|
|
|
Line 288: Line 335:
|-
|-
|[[familial histiocytic reticulosis]]
|[[familial histiocytic reticulosis]]
|
|
|
|
|
Line 295: Line 343:
|-
|-
|[[Gasser syndrome]]
|[[Gasser syndrome]]
|
|
|
|
|
Line 302: Line 351:
|-
|-
|[[GATA1|GATA1-related cytopenia]]
|[[GATA1|GATA1-related cytopenia]]
|
|
|
|
|
Line 309: Line 359:
|-
|-
|[[Glanzmann's thrombasthenia]]
|[[Glanzmann's thrombasthenia]]
|
|
|
|
|
Line 316: Line 367:
|-
|-
|[[grey platelet syndrome]]
|[[grey platelet syndrome]]
|
|
|
|
|
Line 323: Line 375:
|-
|-
|[[hemolytic uremic syndrome]]
|[[hemolytic uremic syndrome]]
|
|
|
|
|
Line 330: Line 383:
|-
|-
|[[histiocytosis X]]
|[[histiocytosis X]]
|
|
|
|
|
Line 337: Line 391:
|-
|-
|[[hypersplenism]]
|[[hypersplenism]]
|
|
|
|
|
Line 344: Line 399:
|-
|-
|[[idiopathic thrombocytopenic purpura]]
|[[idiopathic thrombocytopenic purpura]]
|
|
|
|
|
Line 351: Line 407:
|-
|-
|[[Jacobsen syndrome]]
|[[Jacobsen syndrome]]
|
|
|
|
|
Line 358: Line 415:
|-
|-
|[[Kasabach-Merritt syndrome]]
|[[Kasabach-Merritt syndrome]]
|
|
|
|
|
Line 365: Line 423:
|-
|-
|[[May-Hegglin anomaly]]
|[[May-Hegglin anomaly]]
|
|
|
|
|
Line 372: Line 431:
|-
|-
|[[Moschcowitz syndrome]]
|[[Moschcowitz syndrome]]
|
|
|
|
|
Line 379: Line 439:
|-
|-
|[[myelodysplastic syndrome]]
|[[myelodysplastic syndrome]]
|
|
|
|
|
Line 386: Line 447:
|-
|-
|[[myelofibrosis]]
|[[myelofibrosis]]
|
|
|
|
|
Line 393: Line 455:
|-
|-
|[[neonatal alloimmune thrombocytopenia]]
|[[neonatal alloimmune thrombocytopenia]]
|
|
|
|
|
Line 400: Line 463:
|-
|-
|[[pancytopenia]]
|[[pancytopenia]]
|
|
|
|
|
Line 407: Line 471:
|-
|-
|Paris-Trousseau thrombocytopenia
|Paris-Trousseau thrombocytopenia
|
|
|
|
|
Line 414: Line 479:
|-
|-
|[[paroxysmal nocturnal hemoglobinuria]]
|[[paroxysmal nocturnal hemoglobinuria]]
|
|
|
|
|
Line 421: Line 487:
|-
|-
|[[post-transfusion purpura]]
|[[post-transfusion purpura]]
|
|
|
|
|
Line 428: Line 495:
|-
|-
|[[TAR syndrome|radial aplasia-thrombocytopenia syndrome]]
|[[TAR syndrome|radial aplasia-thrombocytopenia syndrome]]
|
|
|
|
|
Line 435: Line 503:
|-
|-
|[[Sebastian platelet syndrome]]
|[[Sebastian platelet syndrome]]
|
|
|
|
|
Line 442: Line 511:
|-
|-
|[[Shwachman-Diamond syndrome]]
|[[Shwachman-Diamond syndrome]]
|
|
|
|
|
Line 449: Line 519:
|-
|-
|[[thrombotic thrombocytopenic purpura]]
|[[thrombotic thrombocytopenic purpura]]
|
|
|
|
|
Line 456: Line 527:
|-
|-
|[[Von Willebrand disease|Von Willebrand disease, platelet type]]
|[[Von Willebrand disease|Von Willebrand disease, platelet type]]
|
|
|
|
|
Line 463: Line 535:
|-
|-
|[[Werlhof disease]]
|[[Werlhof disease]]
|
|
|
|
|
Line 470: Line 543:
|-
|-
|[[Wiskott-Aldrich syndrome]]
|[[Wiskott-Aldrich syndrome]]
|
|
|
|
|
Line 478: Line 552:
| rowspan="5" |'''Iatrogenic'''
| rowspan="5" |'''Iatrogenic'''
|[[Coronary artery bypass surgery|Cardiac bypass]]
|[[Coronary artery bypass surgery|Cardiac bypass]]
|
|
|
|
|
Line 485: Line 560:
|-
|-
|[[chemotherapy]]
|[[chemotherapy]]
|
|
|
|
|
Line 492: Line 568:
|-
|-
|[[Intra-aortic balloon pump|intra-aortic balloon pump placement]]
|[[Intra-aortic balloon pump|intra-aortic balloon pump placement]]
|
|
|
|
|
Line 499: Line 576:
|-
|-
|[[Blood transfusion|massive blood transfusion]]
|[[Blood transfusion|massive blood transfusion]]
|
|
|
|
|
Line 506: Line 584:
|-
|-
|[[radiation therapy]]
|[[radiation therapy]]
|
|
|
|
|
Line 514: Line 593:
| rowspan="25" |'''Infectious diseases'''
| rowspan="25" |'''Infectious diseases'''
|[[Congenital syphilis]]
|[[Congenital syphilis]]
|
|
|
|
|
Line 521: Line 601:
|-
|-
|[[cytomegalovirus]]
|[[cytomegalovirus]]
|
|
|
|
|
Line 528: Line 609:
|-
|-
|[[Dengue fever]]
|[[Dengue fever]]
|
|
|
|
|
Line 535: Line 617:
|-
|-
|[[ehrlichiosis]]
|[[ehrlichiosis]]
|
|
|
|
|
Line 542: Line 625:
|-
|-
|[[Epstein-Barr virus]]
|[[Epstein-Barr virus]]
|
|
|
|
|
Line 549: Line 633:
|-
|-
|[[hantavirus]]
|[[hantavirus]]
|
|
|
|
|
Line 556: Line 641:
|-
|-
|[[hepatitis C]]
|[[hepatitis C]]
|
|
|
|
|
Line 563: Line 649:
|-
|-
|[[HIV]]
|[[HIV]]
|
|
|
|
|
Line 570: Line 657:
|-
|-
|[[human granulocytic ehrlichiosis]]
|[[human granulocytic ehrlichiosis]]
|
|
|
|
|
Line 577: Line 665:
|-
|-
|[[Ehrlichiosis|human monocytotropic ehrlichiosis]]
|[[Ehrlichiosis|human monocytotropic ehrlichiosis]]
|
|
|
|
|
Line 584: Line 673:
|-
|-
|[[lassa fever]]
|[[lassa fever]]
|
|
|
|
|
Line 591: Line 681:
|-
|-
|[[leptospirosis]]
|[[leptospirosis]]
|
|
|
|
|
Line 598: Line 689:
|-
|-
|[[malaria]]
|[[malaria]]
|
|
|
|
|
Line 605: Line 697:
|-
|-
|[[measles]]
|[[measles]]
|
|
|
|
|
Line 612: Line 705:
|-
|-
|[[mumps]]
|[[mumps]]
|
|
|
|
|
Line 619: Line 713:
|-
|-
|[[mycoplasma pneumonia]]
|[[mycoplasma pneumonia]]
|
|
|
|
|
Line 626: Line 721:
|-
|-
|[[Relapsing fever|Oklahoma tick fever]]
|[[Relapsing fever|Oklahoma tick fever]]
|
|
|
|
|
Line 633: Line 729:
|-
|-
|[[parvovirus]]
|[[parvovirus]]
|
|
|
|
|
Line 640: Line 737:
|-
|-
|[[Q fever]]
|[[Q fever]]
|
|
|
|
|
Line 647: Line 745:
|-
|-
|[[rubella]]
|[[rubella]]
|
|
|
|
|
Line 654: Line 753:
|-
|-
|sepsis
|sepsis
|
|
|
|
|
Line 661: Line 761:
|-
|-
|[[tick-borne encephalitis]]
|[[tick-borne encephalitis]]
|
|
|
|
|
Line 668: Line 769:
|-
|-
|[[Toxic shock syndrome|toxic shock syndrome (staphylococcal)]]
|[[Toxic shock syndrome|toxic shock syndrome (staphylococcal)]]
|
|
|
|
|
Line 675: Line 777:
|-
|-
|[[varicella]]
|[[varicella]]
|
|
|
|
|
Line 682: Line 785:
|-
|-
|[[visceral leishmaniasis]]
|[[visceral leishmaniasis]]
|
|
|
|
|
Line 690: Line 794:
| rowspan="14" |'''Nutritional/Metabolic'''
| rowspan="14" |'''Nutritional/Metabolic'''
|[[folate deficiency]]
|[[folate deficiency]]
|
|
|
|
|
Line 697: Line 802:
|-
|-
|[[Gaucher disease]]
|[[Gaucher disease]]
|
|
|
|
|
Line 704: Line 810:
|-
|-
|[[holocarboxylase synthase deficiency]]
|[[holocarboxylase synthase deficiency]]
|
|
|
|
|
Line 711: Line 818:
|-
|-
|[[iminodipeptiduria]]
|[[iminodipeptiduria]]
|
|
|
|
|
Line 718: Line 826:
|-
|-
|[[iron deficiency]]
|[[iron deficiency]]
|
|
|
|
|
Line 725: Line 834:
|-
|-
|[[isovaleric acidaemia]]
|[[isovaleric acidaemia]]
|
|
|
|
|
Line 732: Line 842:
|-
|-
|[[Methylmalonic aciduria|methylmalonic aciduria type 2]]
|[[Methylmalonic aciduria|methylmalonic aciduria type 2]]
|
|
|
|
|
Line 739: Line 850:
|-
|-
|[[CD36|platelet glycoprotein 4 deficiency]]
|[[CD36|platelet glycoprotein 4 deficiency]]
|
|
|
|
|
Line 746: Line 858:
|-
|-
|[[platelet glycoprotein Ib deficiency]]
|[[platelet glycoprotein Ib deficiency]]
|
|
|
|
|
Line 753: Line 866:
|-
|-
|[[prolidase deficiency]]
|[[prolidase deficiency]]
|
|
|
|
|
Line 760: Line 874:
|-
|-
|[[propionyl-CoA carboxylase deficiency]]
|[[propionyl-CoA carboxylase deficiency]]
|
|
|
|
|
Line 767: Line 882:
|-
|-
|[[sea blue histiocytosis]]
|[[sea blue histiocytosis]]
|
|
|
|
|
Line 774: Line 890:
|-
|-
|[[sitosterolemia]]
|[[sitosterolemia]]
|
|
|
|
|
Line 781: Line 898:
|-
|-
|[[vitamin B12 deficiency]]
|[[vitamin B12 deficiency]]
|
|
|
|
|
Line 789: Line 907:
| rowspan="2" |'''Obstetric/Gynecologic'''
| rowspan="2" |'''Obstetric/Gynecologic'''
|[[Eclampsia]], [[pre-eclampsia]]
|[[Eclampsia]], [[pre-eclampsia]]
|
|
|
|
|
Line 796: Line 915:
|-
|-
|[[HELLP syndrome]]
|[[HELLP syndrome]]
|
|
|
|
|
Line 804: Line 924:
| rowspan="11" |'''Oncologic'''
| rowspan="11" |'''Oncologic'''
|[[Acute lymphoblastic leukemia]]
|[[Acute lymphoblastic leukemia]]
|
|
|
|
|
Line 811: Line 932:
|-
|-
|[[acute myeloid leukemia]]
|[[acute myeloid leukemia]]
|
|
|
|
|
Line 818: Line 940:
|-
|-
|[[acute promyelocytic leukemia]]
|[[acute promyelocytic leukemia]]
|
|
|
|
|
Line 825: Line 948:
|-
|-
|[[chronic lymphocytic leukaemia]]
|[[chronic lymphocytic leukaemia]]
|
|
|
|
|
Line 832: Line 956:
|-
|-
|[[chronic myeloid leukaemia]]
|[[chronic myeloid leukaemia]]
|
|
|
|
|
Line 839: Line 964:
|-
|-
|[[hairy cell leukaemia]]
|[[hairy cell leukaemia]]
|
|
|
|
|
Line 846: Line 972:
|-
|-
|[[hepatosplenic T-cell lymphoma]]
|[[hepatosplenic T-cell lymphoma]]
|
|
|
|
|
Line 853: Line 980:
|-
|-
|[[lymphoma]]
|[[lymphoma]]
|
|
|
|
|
Line 860: Line 988:
|-
|-
|[[myeloma]]
|[[myeloma]]
|
|
|
|
|
Line 867: Line 996:
|-
|-
|[[Non-Hodgkins lymphoma]]
|[[Non-Hodgkins lymphoma]]
|
|
|
|
|
Line 874: Line 1,004:
|-
|-
|[[paraneoplastic syndrome]]
|[[paraneoplastic syndrome]]
|
|
|
|
|
Line 882: Line 1,013:
| rowspan="2" |'''Overdose/Toxicity'''
| rowspan="2" |'''Overdose/Toxicity'''
|[[ethanol]]
|[[ethanol]]
|
|
|
|
|
Line 889: Line 1,021:
|-
|-
|[[arsenic trioxide]]
|[[arsenic trioxide]]
|
|
|
|
|
Line 897: Line 1,030:
|'''Pulmonary'''
|'''Pulmonary'''
|[[Acute respiratory distress syndrome]]
|[[Acute respiratory distress syndrome]]
|
|
|
|
|
Line 905: Line 1,039:
|'''Renal/Electrolyte'''
|'''Renal/Electrolyte'''
|[[hemolytic uremic syndrome]]
|[[hemolytic uremic syndrome]]
|
|
|
|
|
Line 913: Line 1,048:
| rowspan="10" |'''Rheumatology/Immunology/Allergy'''
| rowspan="10" |'''Rheumatology/Immunology/Allergy'''
|[[Anticardiolipin syndrome]]
|[[Anticardiolipin syndrome]]
|
|
|
|
|
Line 920: Line 1,056:
|-
|-
|[[antiphospholipid syndrome]]
|[[antiphospholipid syndrome]]
|
|
|
|
|
Line 927: Line 1,064:
|-
|-
|[[autoimmune lymphoproliferative syndrome type 1]]
|[[autoimmune lymphoproliferative syndrome type 1]]
|
|
|
|
|
Line 934: Line 1,072:
|-
|-
|[[autoimmune lymphoproliferative syndrome type 2]]
|[[autoimmune lymphoproliferative syndrome type 2]]
|
|
|
|
|
Line 941: Line 1,080:
|-
|-
|[[Factor H|complement factor H deficiency]]
|[[Factor H|complement factor H deficiency]]
|
|
|
|
|
Line 948: Line 1,088:
|-
|-
|[[Evans syndrome]]
|[[Evans syndrome]]
|
|
|
|
|
Line 955: Line 1,096:
|-
|-
|[[immunodysregulation polyendocrinopathy and enteropathy, X-linked]]
|[[immunodysregulation polyendocrinopathy and enteropathy, X-linked]]
|
|
|
|
|
Line 962: Line 1,104:
|-
|-
|[[macrophage-activation syndrome]]
|[[macrophage-activation syndrome]]
|
|
|
|
|
Line 969: Line 1,112:
|-
|-
|[[neonatal alloimmune thrombocytopenia]]
|[[neonatal alloimmune thrombocytopenia]]
|
|
|
|
|
Line 976: Line 1,120:
|-
|-
|[[systemic lupus erythematosus]]
|[[systemic lupus erythematosus]]
|
|
|
|
|
Line 984: Line 1,129:
|'''Miscellaneous'''
|'''Miscellaneous'''
|[[Snakebites]]
|[[Snakebites]]
|
|
|
|
|

Revision as of 10:18, 8 August 2018

Thrombocytopenia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Thrombocytopenia from other Diseases

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Thrombocytopenia differential diagnosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Thrombocytopenia differential diagnosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Thrombocytopenia differential diagnosis

CDC on Thrombocytopenia differential diagnosis

Thrombocytopenia differential diagnosis in the news

Blogs on Thrombocytopenia differential diagnosis

Directions to Hospitals Treating Thrombocytopenia

Risk calculators and risk factors for Thrombocytopenia differential diagnosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor-In-Chief: Farbod Zahedi Tajrishi, M.D.

Overview

Thrombocytopenia has a broad range of potential causes. While a good history and physical examination can be helpful to diagnose some of these causes such as drug-induced thrombocytopenia, they usually don't suffice and further evaluation is often needed. There are also some useful points that may guide the physician to an appropriate diagnosis. For example, asymptomatic, isolated thrombocytopenia most probably suggests ITP, while thrombocytopenia in critically ill, hospitalized patients is usually suggestive of iatrogenic causes (eg. dilution), platelet consumption, bone marrow suppression from infection/sepsis, or even drug-induced thrombocytopenia. One should consider however, that a wide variety of other conditions such as autoimmune disorders, nutrient deficiencies, thrombotic microangiopathies could all as well cause thrombocytopenia.

Differential Diagnosis

Category Disease History and symptoms Laboratory findings Pathology Other specifics
WBC changes RBC changes other findings
Cardiovascular endocarditis +/↑ -
pulmonary embolism[1]
Chemical/poisoning Strontium-89
zinc
Dermatologic Cholesterol embolism
Elejalde syndrome
Griscelli syndrome type 1
neuroectodermal melanolysosomal disease
Ear Nose Throat Alport syndrome
Arias oculootoradial syndrome
Epstein's syndrome
Fechtner syndrome
Endocrine Immunodysregulation polyendocrinopathy and enteropathy, X-linked
Gastroenterologic Dibasic aminoaciduria type 2
liver failure
Niemann-Pick disease type b
portal hypertension
Genetic Aicardi-Goutieres syndrome
Chediak-Higashi disease
complement factor H deficiency
Elejalde syndrome
Fanconi anaemia
Fechtner syndrome
Griscelli syndrome type 1
holocarboxylase synthase deficiency
iminodipeptiduria
Jacobsen syndrome
MELAS
Omenn syndrome
TAR syndrome
X-linked hyperimmunoglobulin M syndrome
Hematologic Acquired pure megakaryocytic aplasia
aplastic anemia + / ↓ + / ↓
Bernard-Soulier syndrome
congenital amegakaryocytic thrombocytopenia (CAMT)
disseminated intravascular coagulation
Epstein's syndrome
familial histiocytic reticulosis
Gasser syndrome
GATA1-related cytopenia
Glanzmann's thrombasthenia
grey platelet syndrome
hemolytic uremic syndrome
histiocytosis X
hypersplenism
idiopathic thrombocytopenic purpura
Jacobsen syndrome
Kasabach-Merritt syndrome
May-Hegglin anomaly
Moschcowitz syndrome
myelodysplastic syndrome
myelofibrosis
neonatal alloimmune thrombocytopenia
pancytopenia
Paris-Trousseau thrombocytopenia
paroxysmal nocturnal hemoglobinuria
post-transfusion purpura
radial aplasia-thrombocytopenia syndrome
Sebastian platelet syndrome
Shwachman-Diamond syndrome
thrombotic thrombocytopenic purpura
Von Willebrand disease, platelet type
Werlhof disease
Wiskott-Aldrich syndrome
Iatrogenic Cardiac bypass
chemotherapy
intra-aortic balloon pump placement
massive blood transfusion
radiation therapy
Infectious diseases Congenital syphilis
cytomegalovirus
Dengue fever
ehrlichiosis
Epstein-Barr virus
hantavirus
hepatitis C
HIV
human granulocytic ehrlichiosis
human monocytotropic ehrlichiosis
lassa fever
leptospirosis
malaria
measles
mumps
mycoplasma pneumonia
Oklahoma tick fever
parvovirus
Q fever
rubella
sepsis
tick-borne encephalitis
toxic shock syndrome (staphylococcal)
varicella
visceral leishmaniasis
Nutritional/Metabolic folate deficiency
Gaucher disease
holocarboxylase synthase deficiency
iminodipeptiduria
iron deficiency
isovaleric acidaemia
methylmalonic aciduria type 2
platelet glycoprotein 4 deficiency
platelet glycoprotein Ib deficiency
prolidase deficiency
propionyl-CoA carboxylase deficiency
sea blue histiocytosis
sitosterolemia
vitamin B12 deficiency
Obstetric/Gynecologic Eclampsia, pre-eclampsia
HELLP syndrome
Oncologic Acute lymphoblastic leukemia
acute myeloid leukemia
acute promyelocytic leukemia
chronic lymphocytic leukaemia
chronic myeloid leukaemia
hairy cell leukaemia
hepatosplenic T-cell lymphoma
lymphoma
myeloma
Non-Hodgkins lymphoma
paraneoplastic syndrome
Overdose/Toxicity ethanol
arsenic trioxide
Pulmonary Acute respiratory distress syndrome
Renal/Electrolyte hemolytic uremic syndrome
Rheumatology/Immunology/Allergy Anticardiolipin syndrome
antiphospholipid syndrome
autoimmune lymphoproliferative syndrome type 1
autoimmune lymphoproliferative syndrome type 2
complement factor H deficiency
Evans syndrome
immunodysregulation polyendocrinopathy and enteropathy, X-linked
macrophage-activation syndrome
neonatal alloimmune thrombocytopenia
systemic lupus erythematosus
Miscellaneous Snakebites

References

  1. ↑ Cohen AT, Dobromirski M, Gurwith MM (2014). "Managing pulmonary embolism from presentation to extended treatment". Thromb Res. 133 (2): 139–48. doi:10.1016/j.thromres.2013.09.040. PMID 24182642.

Template:WS Template:WH

Retrieved from "https://www.wikidoc.org/index.php?title=Thrombocytopenia_differential_diagnosis&oldid=1489121"